Books:
Brain Acetycholine and Neuropsychiatric Disease. K.L. Davis, and P.A.
Berger (eds.). Plenum Press, New York, NY.
Alzheimer's Disease: A Report of Progress in Research. Corkin, S., Growdon, J.,
Usdin, E., Davis, K.L., Wurtman, &.d. (eds, Raven Press, New York, NY.
Handbook of Dementia, Delirium and Related Disorders, Vol. LV, Davis, Katzman,
Roth (eds.), Elsevier. Ist Volume scheduled in 1989.

Publications:

1. Wilk, S., Davis, K.L., Thacker, 8.B.: Determination of 3-methoxy-4 hydroxy-
phenylethylene glycol (MHPG) in cerebrospinal fluid. Anal Biochem 32:
1971.

2. Wilk, S., Shopsin, B., Gershon, S., Green, J.P., Davis, K.L.: Catecholamines
and affective disorder levels of MHPG in cerebrospinal fluid.

Pharmacologist 13: 352, 1971.

3. Crowder, R.G., Davis, K.L.: The relation between lisping and visual
recognition memory in children. Perception and Psychophysies 11: 6, 1972.

4. Shopsin, B., Wilk, S., Gershon, 8., Davis, K.L., Shul, M.: Cerebrospinal
fluid MHPG: An assessment of norepinephrine metabolism in affective
disorders. Arch Gen Psychiatry 28: 230-233, 1973.

5. Shopsin, S., Wilk, S., Sathanathan, G., Gershon, A., Davis, K.L.:
Catecholamines and affective disorders revised: A critical assessment.
J. Nerv Ment Dis 158: 369-383, 1974.

6. Davis, K.L., Qualls, B., Hollister, L.E., Stunkard, A.: EEG's of "binge"
eaters, Am J, Psychiatry 131: 1409, 1974.

7. Davis, K.L., Hollister, L.E., Berger, P.A.: Thyrotropin-releasing hormone
in schizophrenia. Am J, Psychiatry 132: 951-953, 1975.

8 Davis, K.L,, Berger, P.A., Hollister, L.E.: Choline for tardive dyskinesia
(a letter). N. Engl J. Med 293: 152, 1975.

9. Hollister, LE., Davis, K.L., Davis, B.M.: Hormones in the treatment of
psychiatric disorders. Hosp Prac 10; 103-110, 1975.

10. Block, S., Brown, 8., Davis, K.L., Dishotsky, N.: The use of a written summary
in group psychotherapy supervision. Am J. Psychiatry 132: 1055-1057, 1975.

11. Davis, K.L, Hollister, LE., Berger, P.A., Barchas, J.D.: Cholinergic
imbalance hypothesis of psychoses and movement disorders: Strategies for
evaluation. Psychopharmacol Comm 1 (5); 533-543, 1975.

 

50287582